NCT00003816 arm group c2f16fd789484acbd0b428fcbda67d03 [clinicaltrials_resource:NCT00003816/arm-group/c2f16fd789484acbd0b428fcbda67d03]
NCT00003816 arm group c2f16fd789484acbd0b428fcbda67d03 [clinicaltrials_resource:NCT00003816/arm-group/c2f16fd789484acbd0b428fcbda67d03]
Bio2RDF identifier
NCT00003816/arm-group/c2f16fd789484acbd0b428fcbda67d03
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... f16fd789484acbd0b428fcbda67d03
description [clinicaltrials_vocabulary:description]
Patients receive cyclophospha ...... ver 24 hours on days -7 to -4.
identifier
clinicaltrials_resource:NCT00003816/arm-group/c2f16fd789484acbd0b428fcbda67d03
title
NCT00003816 arm group c2f16fd789484acbd0b428fcbda67d03
@en
type
label
NCT00003816 arm group c2f16fd7 ...... 16fd789484acbd0b428fcbda67d03]
@en